ANALBIOANAL 2010
TRACK 5(I)
PHARMACOGENOMICS
TRACK 5(II)
POSTGENOMICS: DRUG AND
BIOMARKER DEVELOPMENT
02 November 2010 (Tuesday)
SESSION CHAIR : DR. MICHAEL J. SHAPIRO
University of Maryland School of Pharmacy, Baltimore,
USA
SESSION CO-CHAIR: DR. MICHAEL FIRER
Ariel Center for Applied Cancer Research, Ariel
University Center, Israel
SESSION INTRODUCTION
TITLE: INTERSECTION OF BIOPHYSICAL STUDIES AND DRUG DESIGN. USE
OF THE “EFFICIENCY COEFFICIENT” AND “DRUG DESIGN MATRIX.”
DR. MICHAEL J. SHAPIRO, University of Maryland School of Pharmacy, Baltimore,
USA
TITLE: M-PROTEIN BINDING PEPTIDES FROM PHAGE DISPLAY LIBRARIES
AS BIOMARKERS IN MULTIPLE MYELOMA: A PARADIGM FOR EARLY
DETECTION OF DISEASE RELAPSE
DR. MICHAEL FIRER, Ariel Center for Applied Cancer Research, Ariel University
Center, Israel
TITLE: MULTIPLE RECEPTOR DOCKING AND DOCK POSE CLUSTERING AS A
TOOL FOR COMFA AND COMSIA STUDIES
DR. M. VIJJULATHA, Department of Chemistry, Nizam College, Hyderabad, India
COFFEE BREAK & POSTER SESSION
TITLE: PHARMACOGENETICS /PHARMACOGENOMICS: AN OVERVIEW
DR. SACHDEV YADAV, Department of Pharmacy, Department of Biosciences and
Biotechnology Banasthali, India
TITLE: LEAD MOLECULES FOR MOLECULAR MEDICINE AND OMIC STUDIES
DR. S V ESWARAN, St. Stephen’s College , University of Delhi, India
TITLE: QSAR AND DRUG DESIGNING FOR ANTI-TUMOR/ANTI-CANCER
ACTIVITY
DR. RAMA PANDE, School of Studies in Chemistry, Pt. Ravishankar Shukla
University, India